Healthcare Professionals
Please log in for special information and services
New here?
sign up for personal account

Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio in Germany comprises products in HematoOncology. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

HematoOncology

Anagrelide AOP

Anagrelide AOP® is indicated for the reduction of elevated platelet counts and associated clinical symptoms in at high risk essential thrombocythemia patients.

Drug Facts
Active Ingredient
Anagrelide
HematoOncology

Canemes

Canemes® prevents nausea and vomiting in patients undergoing chemotherapy for malignant tumours and is used if other drugs do not have the desired effect.

Drug Facts
Active Ingredient
Nabilone